RenovoRx (RNXT) Share-based Compensation (2024 - 2025)

RenovoRx (RNXT) has disclosed Share-based Compensation for 2 consecutive years, with $285000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 13.1% to $285000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $666000.0 through Dec 2025, down 18.68% year-over-year, with the annual reading at $1.3 million for FY2025, 7.92% up from the prior year.
  • Share-based Compensation hit $285000.0 in Q4 2025 for RenovoRx, down from $349000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $349000.0 in Q3 2025 to a low of $1000.0 in Q2 2025.